Methylenedioxycyclopropylmethylamphetamine

MDCPM
Names
	Preferred IUPAC name N-(Cyclopropylmethyl)-1-(2H-1,3-benzodioxol-5-yl)propan-2-amine
Identifiers
CAS Number	22698-08-4 ;
3D model (JSmol)	Interactive image;
ChemSpider	21106332 ;
PubChem CID	71308239;
UNII	X8VGM9CN9J ;
CompTox Dashboard (EPA)	DTXSID60745440;
	InChI InChI=1S/C14H19NO2/c1-10(15-8-11-2-3-11)6-12-4-5-13-14(7-12)17-9-16-13/h4-5,7,10-11,15H,2-3,6,8-9H2,1H3 Key: AEIQNPMGFQNZNV-UHFFFAOYSA-N ; InChI=1/C14H19NO2/c1-10(15-8-11-2-3-11)6-12-4-5-13-14(7-12)17-9-16-13/h4-5,7,10-11,15H,2-3,6,8-9H2,1H3 Key: AEIQNPMGFQNZNV-UHFFFAOYAQ;
	SMILES C3OC1C(C=CC(=C1)CC(C)NCC2CC2)O3;
Properties
Chemical formula	C14H19NO2
Molar mass	233.31 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

MDCPM (3,4-methylenedioxy-N-cyclopropylmethylamphetamine) is a lesser-known psychedelic drug. It is the N-cyclopropylmethyl derivative of MDMA. MDCPM was first synthesized by Alexander Shulgin; it is also one of the compounds delineated in a patent by Horrom in 1972.^[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 10 mg, and the duration unknown. MDCPM produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDCPM.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[2]

References

^ U.S. patent 3,689,504
^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

External links

[1] U.S. patent 3,689,504

[2] "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

[1]

[2]

Legality

United Kingdom

See also

References

External links